Please enable JavaScript to continue using this application.

Compare $ANAB vs $REPL | Chartloom

Compare

$ANAB vs $REPL

AnaptysBio Inc · Replimune Group Inc

ANAB

AnaptysBio Inc

REPL

Replimune Group Inc

Compare $ANAB vs $REPL

Comparing AnaptysBio Inc and Replimune Group Inc

ANABAnaptysBio Inc

REPLReplimune Group Inc

ANABAnaptysBio Inc

Market cap

$1.36B

P/E (TTM)

14.99x

Forward P/E (NTM)

16.38x

Forward P/S (NTM)

10.95x

Rev growth (TTM)

92.9%

YTD performance

2.2%

52W performance

44.4%

FCF yield

1.3%

REPLReplimune Group Inc

Market cap

$1.13B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

40.24x

Rev growth (TTM)

—

YTD performance

50.8%

52W performance

188.6%

FCF yield

-24.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANAB

REPL

Detailed metrics comparison

ANAB

AnaptysBio Inc

REPL

Replimune Group Inc

Market Cap

ANAB$1.36B

REPL$1.13B

Enterprise Value

ANAB$1.48B

REPL$1.05B

Price

ANAB$45.95

REPL$13.42

P/E Ratio

ANAB14.99x

REPLN/A

P/S Ratio

ANAB5.73x

REPL0.00x

EV/Sales

ANAB6.24x

REPL0.00x

EV/EBITDA

ANAB10.83x

REPL0.00x

P/B Ratio

ANAB137.06x

REPL11.66x

P/FCF Ratio

ANAB75.37x

REPLN/A

EV/FCF

ANAB82.17x

REPL-3.75x

PEG Ratio

ANABN/A

REPLN/A

Forward P/E (NTM)

ANAB16.38x

REPLN/A

Forward P/S (NTM)

ANAB10.95x

REPL40.24x

Revenue (TTM)

ANAB$238M

REPL$0

Revenue Growth (YoY)

ANAB92.9%

REPLN/A

Forward Rev Growth

ANAB34.7%

REPL397.3%

Gross Margin (TTM)

ANAB0.0%

REPL0.0%

Operating Margin (TTM)

ANAB56.4%

REPL0.0%

EBITDA Margin (TTM)

ANAB56.5%

REPL0.0%

Net Margin (TTM)

ANAB82.4%

REPL0.0%

FCF Margin (TTM)

ANAB7.6%

REPLN/A

Net Income (TTM)

ANAB$196M

REPL$-297M

FCF (TTM)

ANAB$18M

REPL$-281M

EPS (TTM)

ANAB$3.07

REPL-$3.07

ROE (TTM)

ANAB895.0%

REPL-15932.0%

ROA (TTM)

ANAB57.4%

REPL-9084.0%

ROIC (TTM)

ANAB63.2%

REPL-10727.0%

Cash

ANAB$134M

REPL$185M

Debt

ANAB$256M

REPL$109M

Net Cash/Debt

ANAB$-123M

REPL$77M

Current Ratio (TTM)

ANAB5.61x

REPL5.23x

Quick Ratio (TTM)

ANAB5.54x

REPL5.09x

Debt/Equity (TTM)

ANAB24.23x

REPL1.03x

Debt/Assets (TTM)

ANAB0.0%

REPL0.0%

Interest Coverage (TTM)

ANABN/A

REPLN/A

Net Debt/EBITDA (TTM)

ANAB0.00x

REPL0.00x

Beta

ANAB0.82

REPL0.97

52W Performance

ANAB44.4%

REPL188.6%

YTD Performance

ANAB2.2%

REPL50.8%

% from 52W High

ANAB-37.3%

REPL-17.8%

% from 52W Low

ANAB51.8%

REPL794.7%

Asset Turnover (TTM)

ANAB0.70x

REPL0.00x

FCF Yield (TTM)

ANAB1.3%

REPL-24.9%

Earnings Yield (TTM)

ANAB14.4%

REPL-26.3%

Dividend Yield (TTM)

ANABN/A

REPLN/A

Rule of 40

ANAB100.5

REPL0.0

EV/GP/RG

ANABN/A

REPLN/A

Ticker research

View ANAB research View REPL research

Metric	ANAB AnaptysBio Inc	REPL Replimune Group Inc
Market & Valuation
Market Cap	$1.36B	$1.13B
Enterprise Value	$1.48B	$1.05B
Price	$45.95	$13.42
P/E Ratio	14.99x	N/A
P/S Ratio	5.73x	0.00x
EV/Sales	6.24x	0.00x
EV/EBITDA	10.83x	0.00x
P/B Ratio	137.06x	11.66x
P/FCF Ratio	75.37x	N/A
EV/FCF	82.17x	-3.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	16.38x	N/A
Forward P/S (NTM)	10.95x	40.24x
Revenue & Growth
Revenue (TTM)	$238M	$0
Revenue Growth (YoY)	92.9%	N/A
Forward Rev Growth	34.7%	397.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	56.4%	0.0%
EBITDA Margin (TTM)	56.5%	0.0%
Net Margin (TTM)	82.4%	0.0%
FCF Margin (TTM)	7.6%	N/A
Net Income (TTM)	$196M	$-297M
FCF (TTM)	$18M	$-281M
EPS (TTM)	$3.07	-$3.07
ROE (TTM)	895.0%	-15932.0%
ROA (TTM)	57.4%	-9084.0%
ROIC (TTM)	63.2%	-10727.0%
Financial Health
Cash	$134M	$185M
Debt	$256M	$109M
Net Cash/Debt	$-123M	$77M
Current Ratio (TTM)	5.61x	5.23x
Quick Ratio (TTM)	5.54x	5.09x
Debt/Equity (TTM)	24.23x	1.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.82	0.97
52W Performance	44.4%	188.6%
YTD Performance	2.2%	50.8%
% from 52W High	-37.3%	-17.8%
% from 52W Low	51.8%	794.7%
Efficiency & Yields
Asset Turnover (TTM)	0.70x	0.00x
FCF Yield (TTM)	1.3%	-24.9%
Earnings Yield (TTM)	14.4%	-26.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	100.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANAB research	View REPL research

Valuation

P/E Ratio

ANAB

14.99x

P/S Ratio

REPL

0.00x

ANAB

5.73x

EV/FCF

REPL

-3.75x

ANAB

82.17x

Growth & revenue

Revenue Growth TTM

ANAB

92.9%

Forward Revenue Growth

REPL

397.3%

ANAB

34.7%

Profitability & performance

Gross Margin

ANAB

0.0%

REPL

0.0%

ROE

ANAB

895.0%

REPL

-15932.0%

FCF Yield %

ANAB

1.3%

REPL

-24.9%

52-Week Performance

REPL

188.6%

ANAB

44.4%

Detailed metrics comparison

ANAB

AnaptysBio Inc

REPL

Replimune Group Inc

Market Cap

ANAB$1.36B

REPL$1.13B

Enterprise Value

ANAB$1.48B

REPL$1.05B

Price

ANAB$45.95

REPL$13.42

P/E Ratio

ANAB14.99x

REPLN/A

P/S Ratio

ANAB5.73x

REPL0.00x

EV/Sales

ANAB6.24x

REPL0.00x

EV/EBITDA

ANAB10.83x

REPL0.00x

P/B Ratio

ANAB137.06x

REPL11.66x

P/FCF Ratio

ANAB75.37x

REPLN/A

EV/FCF

ANAB82.17x

REPL-3.75x

PEG Ratio

ANABN/A

REPLN/A

Forward P/E (NTM)

ANAB16.38x

REPLN/A

Forward P/S (NTM)

ANAB10.95x

REPL40.24x

Revenue (TTM)

ANAB$238M

REPL$0

Revenue Growth (YoY)

ANAB92.9%

REPLN/A

Forward Rev Growth

ANAB34.7%

REPL397.3%

Gross Margin (TTM)

ANAB0.0%

REPL0.0%

Operating Margin (TTM)

ANAB56.4%

REPL0.0%

EBITDA Margin (TTM)

ANAB56.5%

REPL0.0%

Net Margin (TTM)

ANAB82.4%

REPL0.0%

FCF Margin (TTM)

ANAB7.6%

REPLN/A

Net Income (TTM)

ANAB$196M

REPL$-297M

FCF (TTM)

ANAB$18M

REPL$-281M

EPS (TTM)

ANAB$3.07

REPL-$3.07

ROE (TTM)

ANAB895.0%

REPL-15932.0%

ROA (TTM)

ANAB57.4%

REPL-9084.0%

ROIC (TTM)

ANAB63.2%

REPL-10727.0%

Cash

ANAB$134M

REPL$185M

Debt

ANAB$256M

REPL$109M

Net Cash/Debt

ANAB$-123M

REPL$77M

Current Ratio (TTM)

ANAB5.61x

REPL5.23x

Quick Ratio (TTM)

ANAB5.54x

REPL5.09x

Debt/Equity (TTM)

ANAB24.23x

REPL1.03x

Debt/Assets (TTM)

ANAB0.0%

REPL0.0%

Interest Coverage (TTM)

ANABN/A

REPLN/A

Net Debt/EBITDA (TTM)

ANAB0.00x

REPL0.00x

Beta

ANAB0.82

REPL0.97

52W Performance

ANAB44.4%

REPL188.6%

YTD Performance

ANAB2.2%

REPL50.8%

% from 52W High

ANAB-37.3%

REPL-17.8%

% from 52W Low

ANAB51.8%

REPL794.7%

Asset Turnover (TTM)

ANAB0.70x

REPL0.00x

FCF Yield (TTM)

ANAB1.3%

REPL-24.9%

Earnings Yield (TTM)

ANAB14.4%

REPL-26.3%

Dividend Yield (TTM)

ANABN/A

REPLN/A

Rule of 40

ANAB100.5

REPL0.0

EV/GP/RG

ANABN/A

REPLN/A

Ticker research

View ANAB research View REPL research

Metric	ANAB AnaptysBio Inc	REPL Replimune Group Inc
Market & Valuation
Market Cap	$1.36B	$1.13B
Enterprise Value	$1.48B	$1.05B
Price	$45.95	$13.42
P/E Ratio	14.99x	N/A
P/S Ratio	5.73x	0.00x
EV/Sales	6.24x	0.00x
EV/EBITDA	10.83x	0.00x
P/B Ratio	137.06x	11.66x
P/FCF Ratio	75.37x	N/A
EV/FCF	82.17x	-3.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	16.38x	N/A
Forward P/S (NTM)	10.95x	40.24x
Revenue & Growth
Revenue (TTM)	$238M	$0
Revenue Growth (YoY)	92.9%	N/A
Forward Rev Growth	34.7%	397.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	56.4%	0.0%
EBITDA Margin (TTM)	56.5%	0.0%
Net Margin (TTM)	82.4%	0.0%
FCF Margin (TTM)	7.6%	N/A
Net Income (TTM)	$196M	$-297M
FCF (TTM)	$18M	$-281M
EPS (TTM)	$3.07	-$3.07
ROE (TTM)	895.0%	-15932.0%
ROA (TTM)	57.4%	-9084.0%
ROIC (TTM)	63.2%	-10727.0%
Financial Health
Cash	$134M	$185M
Debt	$256M	$109M
Net Cash/Debt	$-123M	$77M
Current Ratio (TTM)	5.61x	5.23x
Quick Ratio (TTM)	5.54x	5.09x
Debt/Equity (TTM)	24.23x	1.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.82	0.97
52W Performance	44.4%	188.6%
YTD Performance	2.2%	50.8%
% from 52W High	-37.3%	-17.8%
% from 52W Low	51.8%	794.7%
Efficiency & Yields
Asset Turnover (TTM)	0.70x	0.00x
FCF Yield (TTM)	1.3%	-24.9%
Earnings Yield (TTM)	14.4%	-26.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	100.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANAB research	View REPL research